Payments to Acquire Property, Plant, and Equipment of RVL Pharmaceuticals plc from 31 Dec 2017 to 31 Mar 2023

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
RVL Pharmaceuticals plc quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2017 to 31 Mar 2023.
  • RVL Pharmaceuticals plc Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2023 was $1,304,000, a 4730% increase year-over-year.
  • RVL Pharmaceuticals plc annual Payments to Acquire Property, Plant, and Equipment for 2022 was $752,000, a 58% decline from 2021.
  • RVL Pharmaceuticals plc annual Payments to Acquire Property, Plant, and Equipment for 2021 was $1,782,000, a 39% decline from 2020.
  • RVL Pharmaceuticals plc annual Payments to Acquire Property, Plant, and Equipment for 2020 was $2,920,000, a 26% decline from 2019.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

RVL Pharmaceuticals plc Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2023 $1,304,000 +$1,277,000 +4730% 01 Jan 2023 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q1 2022 $27,000 -$395,000 -94% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $422,000 -$527,000 -56% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $949,000 +$314,000 +49% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q1 2019 $635,000 -$801,771 -56% 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020 2020 Q1
Q1 2018 $1,436,771 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1

RVL Pharmaceuticals plc Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $752,000 -$1,030,000 -58% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2023 2022 FY
2021 $1,782,000 -$1,138,000 -39% 01 Jan 2021 31 Dec 2021 10-K 20 Mar 2023 2022 FY
2020 $2,920,000 -$1,043,000 -26% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2022 2021 FY
2019 $3,963,000 -$181,000 -4.4% 01 Jan 2019 31 Dec 2019 8-K 08 Sep 2021
2018 $4,144,000 -$2,751,332 -40% 01 Jan 2018 31 Dec 2018 10-K 19 Mar 2020 2019 FY
2017 $6,895,332 01 Jan 2017 31 Dec 2017 8-K 20 Dec 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.